The weekly litigation news digest is live. Subscribe now

Hgf competitive analysis

Explore patent oppositions filed by Hgf against competitors, revealing strategic technology disputes and market positioning.

Last updated on: Jan 15, 2026
Patent NumberTitleApplicantOpposition Date
Methods And Compositions For Rna-Directed Target Dna Modification And For Rna-Directed Modulation Of TranscriptionCHARPENTIERNov 25, 2025
Methods And Materials For Assessing Allelic ImbalanceMYRIAD GENETICSNov 18, 2025
Methods And Compositions For Treating VitiligoCENTRE HOSPITALIER UNIVERSITAIRE DE NICESep 3, 2025
Treatment Of Cancer By Manipulation Of Commensal MicrofloraTHE UNIVERSITY OF CHICAGOJul 16, 2025
Modulation Of Ube3A-Ats ExpressionBAYLOR COLLEGE OF MEDICINEApr 16, 2025
An Anhydrous Pharmaceutical Composition For Maintenance Treatment Of PsoriasisLEO PHARMAFeb 24, 2025
Cylodextrin Complexation Methods For Formulating Peptide Proteasome InhibitorsONYX THERAPEUTICSJan 17, 2025
Hyperactive Piggybac TransposasesPOSEIDA THERAPEUTICSJan 2, 2025
Methods Of Treating Hepatic Encephalopathy Using RifaximinSALIX PHARMACEUTICALSNov 4, 2024
Pharmaceutical Composition Comprising Glucopyranosyl Diphenylmethane Derivatives, Pharmaceutical Dosage Form Thereof, Process For Their Preparation And Uses Thereof For Improved Glycemic Control In A PatientBOEHRINGER INGELHEIMOct 17, 2024

Latest PTAB cases involving Hgf

Discover the latest PTAB cases involving Hgf, highlighting their recent legal challenges and patent disputes.

Peer Comparison New

IP litigation analysis comparing Hgf with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Jan 15, 2026
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases Faced
HGF76 - - -
CHARPENTIER - 21 - -
NOVARTIS6423 - 21
THE REGENTS OF THE UNIVERSITY OF CALIFORNIA - 35 - 19